Cornell is one of only seven institutions across the U.S. that will receive a funding award from the National Institutes of Health through a program aimed at increasing minority faculty in the biomedical sciences.
The Eclectic Convergence conference included talks from six entrepreneurs, business executives and venture capitalists, as well as a pitch competition.
The pathogen listeria soon may become easier to track down in food recalls, thanks to a new genomic and geological mapping tool created by Cornell food scientists.
Elucida Oncology, a biotechnology company based on C Dots – ultra-small nanoparticles developed at Cornell that show promise in identifying and fighting cancer – recently secured $44 million in financing.
Embark Veterinary, Inc. – a canine genetics startup company that graduated from Cornell’s McGovern Center incubator in late 2017 – announced $75 million in venture funding on July 26.
A true believer in mediation and arbitration techniques as a means of solving societal problems, Marcia Greenbaum’s work was felt across the nation and in Eastern Europe.
The Samuel Curtis Johnson Graduate School of Management is announcing a new BioEntrepreneurship Initiative to connect MBA students and life science researchers to life science companies in NYS while catalyzing the formation of new life science startups.
Research from the Kurpios lab reveals the complex signaling that directs formation of intestinal lacteals, the lymphatic channels required for fat absorption in vertebrates.
Paula Cohen, associate vice provost for life sciences, is leading an eight-year, $8 million, multi-institution grant to untangle the complex genetic rulebook for how sperm develops.
A Baker Institute for Animal Health study finds the antimicrobial properties of certain stem cell proteins could help treat skin infections that are resistant to antibiotics.